Livzon Pharmaceutical Group, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100001QV5
HKD
31.00
0.58 (1.91%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
12,652.62
13,567.74
14,516.34
14,373.87
11,682.80
10,518.14
10,354.73
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
12,652.62
13,567.74
14,516.34
14,373.87
11,682.80
10,518.14
10,354.73
Raw Material Cost
4,627.52
5,438.72
5,545.85
5,330.80
4,275.57
4,003.19
4,118.52
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
1,872.22
1,747.88
1,877.74
1,627.89
1,314.22
1,222.89
1,076.37
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
100.84
118.11
119.84
105.90
34.12
12.49
23.52
Selling and Distribution Expenses
4,109.46
4,608.44
5,186.70
5,380.46
4,120.53
4,145.26
4,402.11
Other Expenses
-96.36
-79.06
-59.23
-44.79
-41.86
-48.03
-51.02
Total Expenditure (Excl Depreciation)
9,746.49
11,122.54
12,137.82
11,997.13
9,325.81
8,903.56
9,110.32
Operating Profit (PBDIT) excl Other Income
2906.1000000000004
2445.2000000000003
2378.5
2376.7
2357
1614.6000000000001
1244.4
Other Income
416.86
589.16
597.95
489.76
534.02
422.43
573.50
Operating Profit (PBDIT)
3,860.77
3,670.14
3,615.94
3,368.26
3,303.18
2,452.00
2,207.22
Interest
100.84
118.11
119.84
105.90
34.12
12.49
23.52
Exceptional Items
-129.03
-26.44
-85.12
-34.85
15.73
2.63
-46.44
Gross Profit (PBDT)
8,025.10
8,129.02
8,970.48
9,043.07
7,407.23
6,514.95
6,236.21
Depreciation
599.10
957.35
772.00
568.06
489.57
471.14
451.95
Profit Before Tax
3,031.79
2,568.24
2,638.98
2,659.45
2,795.22
1,971.01
1,685.31
Tax
543.91
536.00
436.05
353.84
402.40
301.58
278.30
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
2,234.69
2,158.78
2,220.41
2,140.07
1,927.03
1,477.35
1,281.79
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
2,234.69
2,158.78
2,220.41
2,140.07
1,927.03
1,477.35
1,281.79
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
263.89
-61.93
53.69
212.62
467.92
179.95
117.90
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
2,498.58
2,096.85
2,274.10
2,352.69
2,394.96
1,657.31
1,399.69
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.06
1.1
1.12
1.22
0.0
0.0
0.0
Reserves
14,752.46
15,460.86
15,579.21
15,907.06
14,354.83
12,491.08
12,147.06
Earnings per share (EPS)
2.43
2.32
2.37
2.29
2.05
1.58
1.37
Diluted Earnings per share
2.43
2.32
2.37
2.29
2.05
1.58
1.37
Operating Profit Margin (Excl OI)
22.48%
15.65%
15.47%
16.07%
19.51%
14.82%
11.41%
Gross Profit Margin
28.7%
25.99%
23.5%
22.45%
28.12%
23.22%
20.64%
PAT Margin
17.66%
15.91%
15.3%
14.89%
16.49%
14.05%
12.38%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is -6.74% vs -6.53% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 19.16% vs -7.80% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 11.78% vs 2.09% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is -14.65% vs -1.42% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Compare Annual Results Of Livzon Pharmaceutical Group, Inc. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(HKD)
Change(%)
Net Sales
12,652.62
683.03
11,969.59
1,752.43%
Other Operating Income
0.00
0.00
0.00
Total Operating income
12,652.62
683.03
11,969.59
1,752.43%
Raw Material Cost
4,627.52
231.12
4,396.40
1,902.22%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
1,872.22
142.44
1,729.78
1,214.39%
Power Cost
0
0
0.00
Manufacturing Expenses
100.84
15.57
85.27
547.66%
Selling and Distribution Expenses
4,109.46
340.58
3,768.88
1,106.61%
Other Expenses
-96.36
9.69
-106.05
-1,094.43%
Total Expenditure (Excl Depreciation)
9,746.49
826.61
8,919.88
1,079.09%
Operating Profit (PBDIT) excl Other Income
2,906.12
-143.58
3,049.70
2,124.04%
Other Income
416.86
27.23
389.63
1,430.89%
Operating Profit (PBDIT)
3,860.77
-24.89
3,885.66
15,611.33%
Interest
100.84
15.57
85.27
547.66%
Exceptional Items
-129.03
0.00
-129.03
Gross Profit (PBDT)
8,025.10
451.91
7,573.19
1,675.82%
Depreciation
599.10
91.46
507.64
555.04%
Profit Before Tax
3,031.79
-131.91
3,163.70
2,398.38%
Tax
543.91
0.00
543.91
Provisions and contingencies
0
0
0.00
Profit After Tax
2,234.69
-131.91
2,366.60
1,794.10%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
2,234.69
-131.91
2,366.60
1,794.10%
Share in Profit of Associates
0
0
0.00
Minority Interest
263.89
0.00
263.89
Other related items
0.00
0.00
0.00
Consolidated Net Profit
2,498.58
-131.91
2,630.49
1,994.16%
Equity Capital
0
0
0.00
Face Value
1.06
1.10
0.00
Reserves
14,752.46
1,453.18
13,299.28
915.18%
Earnings per share (EPS)
2.43
-0.26
2.69
1,034.62%
Diluted Earnings per share
2.43
-0.26
2.69
1,034.62%
Operating Profit Margin (Excl OI)
22.48%
-21.02%
0.00
43.50%
Gross Profit Margin
28.70%
-5.92%
0.00
34.62%
PAT Margin
17.66%
-19.31%
0.00
36.97%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 1,265.26 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -6.74% vs -6.53% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 249.86 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 19.16% vs -7.80% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 344.39 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 11.78% vs 2.09% in Dec 2023

Annual - Interest
Interest 10.08 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -14.65% vs -1.42% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 22.48%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has improved from Dec 2023